Universe Pharmaceuticals (UPC) Assets Average (2021 - 2026)
Universe Pharmaceuticals (UPC) posted Assets Average of $70.4 million for Q1 2026, down 99.79% sequentially from $34.0 billion in Q3 2025.
Universe Pharmaceuticals (UPC) Assets Average (2021 - 2026) Analysis & Trends
Universe Pharmaceuticals has reported Assets Average for 6 years, with the latest figure at $70.4 million in Q1 2026.
- Quarterly Assets Average changed N/A year-over-year to $70.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.4 million (changed N/A YoY) and the FY2025 annual result came in at $34.0 billion, changed 0.04% from the prior year.
- Assets Average fell to $70.4 million in Q1 2026 per UPC's latest filing, from $34.0 billion in the prior quarter.
- Over five years, Assets Average peaked at $34.0 billion in Q3 2025 and troughed at $45.6 million in Q1 2024.
- A 5-year average of $8.5 billion and a median of $67.9 million in 2022 frame the typical range for Assets Average.
- The widest YoY moves for Assets Average: up 60566.53% in 2024, down 29.83% in 2024.
- Over 5 years, Assets Average stood at $65.5 million in 2022, then decreased by 14.37% to $56.0 million in 2023, then soared by 60566.53% to $34.0 billion in 2024, then advanced by 0.03% to $34.0 billion in 2025, then tumbled by 99.79% to $70.4 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $70.4 million, $34.0 billion, and $34.0 billion for Q1 2026, Q3 2025, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Universe Pharmaceuticals | 3.04 Mn | -26.01 Mn | - | 70.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.38 Mn |
| Sep 30, 2025 | 34.01 Bn |
| Sep 30, 2024 | 34.00 Bn |
| Mar 31, 2024 | 45.58 Mn |
| Sep 30, 2023 | 56.05 Mn |
| Mar 31, 2023 | 64.95 Mn |
| Sep 30, 2022 | 65.45 Mn |
| Mar 31, 2022 | 70.76 Mn |
| Sep 30, 2021 | 35.07 Mn |